Études de suivi < Études longitudinales < Études multicentriques comme sujet

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by Études longitudinales

Number of relevant bibliographic references: 20.

Ident.	Authors (with country if any)	Title
000855 (2019)	Christoph T. Berger [Suisse] ; Birke Rebholz-Chaves [Suisse] ; Mike Recher [Suisse] ; Tobias Manigold [Suisse] ; Thomas Daikeler [Suisse]	Serial IL-6 measurements in patients with tocilizumab-treated large-vessel vasculitis detect infections and may predict early relapses.
000B34 (2019)	Sibel Balci [Turquie] ; Rabia Miray Kisla Ekinci [Turquie] ; Aysun Karabay Bayazit [Turquie] ; Engin Melek [Turquie] ; Dilek Dogruel [Turquie] ; Derya Ufuk Altintas [Turquie] ; Mustafa Yilmaz [Turquie]	Juvenile systemic lupus erythematosus: a single-center experience from southern Turkey.
000E92 (2019)	Sezgin Sahin [Turquie] ; Duhan Hopurcuoglu [Turquie] ; Sule Bektas [Turquie] ; Ezgi Belhan [Turquie] ; Amra Adrovic [Turquie] ; Kenan Barut [Turquie] ; Nur Canpolat [Turquie] ; Salim Caliskan [Turquie] ; Lale Sever [Turquie] ; Ozgur Kasapcopur [Turquie]	Childhood-onset Takayasu arteritis: A 15-year experience from a tertiary referral center.
001584 (2017)	Wenhui Wei [États-Unis] ; Keith Knapp [États-Unis] ; Li Wang [États-Unis] ; Chieh-I Chen [États-Unis] ; Gary L. Craig [États-Unis] ; Karen Ferguson [États-Unis] ; Sergio Schwartzman [États-Unis]	Treatment Persistence and Clinical Outcomes of Tumor Necrosis Factor Inhibitor Cycling or Switching to a New Mechanism of Action Therapy: Real-world Observational Study of Rheumatoid Arthritis Patients in the United States with Prior Tumor Necrosis Factor Inhibitor Therapy.
001661 (2017)	Olafur Sveinsson [Suède] ; Mathias Granqvist [Suède] ; Yngve Forslin [Suède] ; Kaj Blennow [Suède] ; Henrik Zetterberg [Royaume-Uni] ; Fredrik Piehl [Suède]	Successful combined targeting of B- and plasma cells in treatment refractory anti-NMDAR encephalitis.
001813 (2017)	Achille Marino [Italie] ; Sona Narula [États-Unis] ; Melissa A. Lerman [États-Unis]	First Pediatric Patient With Neuromyelitis Optica and Sjögren Syndrome Successfully Treated With Tocilizumab.
001830 (2017)	Carolin Wunderlich [Allemagne] ; Isabelle Oliviera [Allemagne] ; Camille P. Figueiredo [Brésil] ; Juergen Rech [Allemagne] ; Georg Schett [Allemagne]	Effects of DMARDs on citrullinated peptide autoantibody levels in RA patients-A longitudinal analysis.
001B87 (2016)	Valérie Devauchelle-Pensec [France] ; Jean Marie Berthelot [France] ; Divi Cornec [France] ; Yves Renaudineau [France] ; Thierry Marhadour [France] ; Sandrine Jousse-Joulin [France] ; Solène Querellou [France] ; Florent Garrigues [France] ; Michel De Bandt [France] ; Maelenn Gouillou [France] ; Alain Saraux [France]	Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study
001B98 (2016)	Michelle J. Ormseth [États-Unis] ; Patricia G. Yancey [États-Unis] ; Joseph F. Solus [États-Unis] ; S Louis Bridges ; Jeffrey R. Curtis ; Macrae F. Linton [États-Unis] ; Sergio Fazio [États-Unis] ; Sean S. Davies [États-Unis] ; L Jackson Roberts [États-Unis] ; Kasey C. Vickers [États-Unis] ; Valentina Kon [États-Unis] ; C. Michael Stein [États-Unis]	Effect of Drug Therapy on Net Cholesterol Efflux Capacity of High-Density Lipoprotein-Enriched Serum in Rheumatoid Arthritis.
001E83 (2015)	Sella Aarrestad Provan [Norvège] ; Inger Jorid Berg [Norvège] ; Hilde Berner Hammer [Norvège] ; Alexander Mathiessen [Norvège] ; Tore Kristian Kvien [Norvège] ; Anne Grete Semb [Norvège]	The Impact of Newer Biological Disease Modifying Anti-Rheumatic Drugs on Cardiovascular Risk Factors: A 12-Month Longitudinal Study in Rheumatoid Arthritis Patients Treated with Rituximab, Abatacept and Tociliziumab.
001F49 (2015)	Maarit Tarkiainen [Finlande] ; Pirjo Tynj L [Finlande] ; Paula V H Salo [Finlande] ; Pekka Lahdenne [Finlande]	Occurrence of adverse events in patients with JIA receiving biologic agents: long-term follow-up in a real-life setting.
002000 (2015)	S. Nimmrich [Oman] ; G. Horneff	Incidence of herpes zoster infections in juvenile idiopathic arthritis patients.
002035 (2015)	Nada Bensaoud [France] ; Samira Rostom ; Rachid Bahiri ; Najia Hajjaj-Hassouni	Efficacy of tocilizumab on MRI-determined bone oedema in rheumatoid arthritis.
002043 (2015)	G. Cavalli [Italie] ; S. Franchini ; P. Aiello ; B. Guglielmi ; A. Berti ; C. Campochiaro ; M G Sabbadini ; E. Baldissera ; L. Dagna	Efficacy and safety of biological agents in adult-onset Still's disease.
002074 (2015)	Maria K. Kvamme [Norvège] ; Elisabeth Lie [Norvège] ; Till Uhlig [Norvège] ; Tron A. Moger [Norvège] ; Tore K. Kvien [Norvège] ; Ivar S. Kristiansen [Norvège]	Cost-effectiveness of TNF inhibitors vs synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a Markov model study based on two longitudinal observational studies.
002362 (2014)	Yasuharu Nakashima [Japon] ; Masakazu Kondo ; Takaaki Fukuda ; Hiroshi Harada ; Takahiko Horiuchi ; Takashi Ishinishi ; Hiroshi Jojima ; Koji Kuroda ; Hisaaki Miyahara ; Masayuki Maekawa ; Hiroaki Nishizaka ; Ryuji Nagamine ; Hitoshi Nakashima ; Takeshi Otsuka ; Eisuke Shono ; Eiichi Suematsu ; Takashi Shimauchi ; Tomomi Tsuru ; Ken Wada ; Shigeru Yoshizawa ; Seiji Yoshizawa ; Yukihide Iwamoto	Remission in patients with active rheumatoid arthritis by tocilizumab treatment in routine clinical practice: results from 3 years of prospectively registered data.
002484 (2014)	T W J. Huizinga [Pays-Bas] ; Philip G. Conaghan [Royaume-Uni] ; Emilio Martin-Mola [Espagne] ; Georg Schett [Allemagne] ; Howard Amital [Israël] ; Ricardo M. Xavier [Brésil] ; Orrin Troum [États-Unis] ; Maher Aassi ; Corrado Bernasconi ; Maxime Dougados [France]	Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study
004287 (????)	Irene Notario Ferreira [Espagne] ; Miguel Angel Ferrer González [Espagne] ; Pilar Morales Garrido [Espagne] ; Alfonso González Utrilla [Espagne] ; Antonio García Sanchez [Espagne] ; María José Soto Pino [Espagne] ; Evelyn Suero Rosario [Espagne] ; Cristina Caro Hernández [Espagne] ; Isabel A N O Ate [Espagne] ; Lorena Pérez Albaladejo [Espagne] ; Rafael Cáliz Cáliz [Espagne]	Two-year efficacy of tocilizumab in patients with active rheumatoid arthritis in clinical practice.
004336 (????)	Leticia Leon [Espagne] ; Alejandro Gomez [Espagne] ; Cristina Vadillo [Espagne] ; Esperanza Pato [Espagne] ; Luis Rodriguez-Rodriguez [Espagne] ; Juan Angel Jover [Espagne] ; Lydia Abasolo [Espagne]	Severe adverse drug reactions to biological disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis in clinical practice.
004443 (????)	Florenzo Iannone [Italie] ; Marilina Tampoia [Italie] ; Margherita Giannini [Italie] ; Giuseppe Lopalco [Italie] ; Luca Cantarini [Italie] ; C Danilo Villalta [Italie] ; Mauro Galeazzi [Italie] ; Giovanni Lapadula [Italie]	Changes in anti-cyclic citrullinated peptide antibodies and rheumatoid factor isotypes serum levels in patients with rheumatoid arthritis following treatment with different biological drugs.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i -k "Études longitudinales" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i  \
                -Sk "Études longitudinales" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    MeshFr.i
   |clé=    Études longitudinales
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021